Perbedaan Charlie Hospital Semarang Tbk. dan Chandra Asri Pacific Tbk.: Charlie Hospital Semarang Tbk. diperdagangkan di Rp306 (kapitalisasi pasar 816,2 M, volume 24 jam 16,3 jt), sedangkan Chandra Asri Pacific Tbk. diperdagangkan di Rp2.060 (kapitalisasi pasar 186,86 T, volume 24 jam 222,58 jt). Perbedaan utamanya: Chandra Asri Pacific Tbk. jauh lebih besar — sekitar 228,9× kapitalisasi pasar Charlie Hospital Semarang Tbk., dan Chandra Asri Pacific Tbk. lebih aktif diperdagangkan (222,58 jt vs 16,3 jt). Mana yang lebih baik tergantung tujuan investasimu.
| RSCH | TPIA | |
|---|---|---|
Kapitalisasi Pasar | 816,2 M | 186,86 T |
Volume | 16,3 jt | 222,58 jt |
Lot | 163,02 rb | 2,23 jt |
Perputaran | 5,01 M | 464,89 M |
Harga Rata-rata | 307,42 | 2.088,6 |
Nilai Transaksi | 5,01 M | 464,89 M |
Harga Ekuilibrium Indikatif | 312 | 2.150 |
Volume Ekuilibrium Indikatif | 8 | 51,23 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Selengkapnya di halaman TPIA →